These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16858677)

  • 21. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.
    Zeng Z; Zhou Y; Xiong W; Luo X; Zhang W; Li X; Fan S; Cao L; Tang K; Wu M; Li G
    J Cancer Res Clin Oncol; 2007 Feb; 133(2):71-81. PubMed ID: 16941191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression.
    Kuo YS; Tang YB; Lu TY; Wu HC; Lin CT
    J Pathol; 2010 Nov; 222(3):299-309. PubMed ID: 20635349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells.
    Lee JW; Hsiao WT; Chen HY; Hsu LP; Chen PR; Lin MD; Chiu SJ; Shih WL; Hsu YC
    Int J Cancer; 2010 Mar; 126(6):1353-66. PubMed ID: 19739116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
    Yang H; Zhao R; Lee MH
    Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
    Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
    Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
    Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.
    Chai SJ; Ahmad Zabidi MM; Gan SP; Rajadurai P; Lim PVH; Ng CC; Yap LF; Teo SH; Lim KP; Patel V; Cheong SC
    Dis Markers; 2019; 2019():3857853. PubMed ID: 31236144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differentially expressed genes between upward and downward progressing types of nasopharyngeal carcinoma].
    Liang WJ; Qiu F; Hong MH; Guo L; Qin HD; Liu QC; Zhang XS; Mai HQ; Xiang YQ; Min HQ; Zeng YX
    Ai Zheng; 2008 May; 27(5):460-5. PubMed ID: 18479593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines.
    Ai MD; Li LL; Zhao XR; Wu Y; Gong JP; Cao Y
    Cell Res; 2005 Oct; 15(10):777-84. PubMed ID: 16246267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differentially expressed transcription factor-related genes in nasopharyngeal carcinoma and nasopharyngeal tissues].
    Wang S; Lu LC; Fang WY; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):146-9. PubMed ID: 17355921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
    Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
    Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient.
    Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
    Clin Cancer Res; 2003 Mar; 9(3):1033-8. PubMed ID: 12631603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
    Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
    Xie L; Xu L; He Z; Zhou W; Wang L; Zhang L; Lan K; Ren C; Liu W; Yao K
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):400-6. PubMed ID: 10929762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential gene expression profiling for identification of protective transcription factors in different subtypes of nasopharyngeal carcinoma].
    Huang C; Lin P; Wang J; Huang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1565-70. PubMed ID: 24273254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways.
    Fu WM; Lu YF; Hu BG; Liang WC; Zhu X; Yang HD; Li G; Zhang JF
    Oncotarget; 2016 Jan; 7(4):4712-23. PubMed ID: 26717040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of splicing variants in NASG 3'UTR, down-regulated in nasopharyngeal carcinoma, and its expression in multiple cancer tissues].
    Zhang BC; Zhu SG; Xiang JJ; Zhou M; Nie XM; Xiao BY; Li XL; Li GY
    Ai Zheng; 2003 May; 22(5):477-80. PubMed ID: 12753706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene expression profile of immune cells from patients with nasopharyngeal carcinoma of stage T3-4N0].
    Xiao XB; Mai HQ; Cao SM; Zhang Y; Sun R; Hong MH
    Ai Zheng; 2005 Feb; 24(2):135-40. PubMed ID: 15694020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.